Synopsis of recent research by authors named "Vei Mah"
- Vei Mah's recent research primarily focuses on identifying biomarkers and regulatory mechanisms in aggressive cancer types, particularly triple-negative breast cancer (TNBC) and endometrial cancer, to enhance treatment outcomes and prognostic evaluation.
- Significant findings include the identification of EMP2 as a functional biomarker for chemotherapy-resistant TNBC and the role of ALDH1 expression in predicting cancer progression from premalignant lesions in Type I endometrial carcinomas.
- Additional contributions involve exploring the metabolic pathways in cancer cells, as evidenced by studies on MCT1 and its influence on tumor growth, and the expression of proteins such as AGR2 and RRM2 in prognosis and cancer survivability.
